Mintz Levin attorneys advise and counsel managed care organizations on a wide range of complex legal, regulatory, and legislative issues, many of which stem from the passage of the Medicare Prescription Drug Improvement and Modernization Act of 2003. We advise Medicare Advantage (MA) organizations and Medicare Part D plans on various program requirements, including:
We advocate on behalf of our clients before the Centers for Medicare & Medicaid Services (CMS) and assist plans in preparing for and responding to CMS and Office of Inspector General for the Department of Health and Human Services (OIG)audits and special studies.